BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 25274536)

  • 1. Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populations.
    Liu F; Ranmal S; Batchelor HK; Orlu-Gul M; Ernest TB; Thomas IW; Flanagan T; Tuleu C
    Drugs; 2014 Oct; 74(16):1871-1889. PubMed ID: 25274536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient centric formulations for paediatrics and geriatrics: Similarities and differences.
    Hanning SM; Lopez FL; Wong IC; Ernest TB; Tuleu C; Orlu Gul M
    Int J Pharm; 2016 Oct; 512(2):355-359. PubMed ID: 26976504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of acceptability of oral paediatric medicines: a review.
    Mistry P; Batchelor H;
    J Pharm Pharmacol; 2017 Apr; 69(4):361-376. PubMed ID: 27524471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of formulation factors that affect oral medicines acceptability in a domiciliary paediatric population.
    Venables R; Batchelor H; Hodson J; Stirling H; Marriott J
    Int J Pharm; 2015 Mar; 480(1-2):55-62. PubMed ID: 25601436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient Acceptability and Preferences for Solid Oral Dosage Form Drug Product Attributes: A Scoping Review.
    Hauber B; Hand MV; Hancock BC; Zarrella J; Harding L; Ogden-Barker M; Antipas AS; Watt SJ
    Patient Prefer Adherence; 2024; 18():1281-1297. PubMed ID: 38919378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methodologies for assessing the acceptability of oral formulations among children and older adults: a systematic review.
    Ranmal SR; O'Brien F; Lopez F; Ruiz F; Orlu M; Tuleu C; Walsh J; Liu F
    Drug Discov Today; 2018 Apr; 23(4):830-847. PubMed ID: 29371123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safe, swallowable and palatable paediatric mini-tablet formulations for a WHO model list of essential medicines for children compound - A promising starting point for future PUMA applications.
    Freerks L; Sommerfeldt J; Löper PC; Klein S
    Eur J Pharm Biopharm; 2020 Nov; 156():11-19. PubMed ID: 32871197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation factors affecting acceptability of oral medicines in children.
    Liu F; Ranmal S; Batchelor HK; Orlu-Gul M; Ernest TB; Thomas IW; Flanagan T; Kendall R; Tuleu C;
    Int J Pharm; 2015 Aug; 492(1-2):341-3. PubMed ID: 25959115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensory aspects of acceptability of bitter-flavoured 7.5 mm film-coated tablets in adults, preschool and school children.
    Hofmanová JK; Mason J; Batchelor HK
    Int J Pharm; 2020 Jul; 585():119511. PubMed ID: 32522503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paediatric Drug Development and Formulation Design-a European Perspective.
    Van Riet-Nales DA; Kozarewicz P; Aylward B; de Vries R; Egberts TC; Rademaker CM; Schobben AF
    AAPS PharmSciTech; 2017 Feb; 18(2):241-249. PubMed ID: 27270905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing patient-centric medicines for older people: Reflections from the draft EMA paper on the pharmaceutical development of medicines for use in the older population.
    van Riet-Nales DA; Sundberg K; de Boer A; Hirschlérova B
    Br J Clin Pharmacol; 2020 Oct; 86(10):2008-2013. PubMed ID: 32830323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceptability of oral solid medicines in older adults with and without dysphagia: A nested pilot validation questionnaire based observational study.
    Liu F; Ghaffur A; Bains J; Hamdy S
    Int J Pharm; 2016 Oct; 512(2):374-381. PubMed ID: 26970368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric formulation issues identified in Paediatric Investigation Plans.
    Quijano Ruiz B; Desfontaine E; Arenas-López S; Wang S
    Expert Rev Clin Pharmacol; 2014 Jan; 7(1):25-30. PubMed ID: 24308789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation of medicines for children.
    Nunn T; Williams J
    Br J Clin Pharmacol; 2005 Jun; 59(6):674-6. PubMed ID: 15948931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An industrial perspective on the design and development of medicines for older patients.
    Page S; Coupe A; Barrett A
    Int J Pharm; 2016 Oct; 512(2):352-354. PubMed ID: 27001530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptability of oral liquid pharmaceutical products in older adults: palatability and swallowability issues.
    Belissa E; Vallet T; Laribe-Caget S; Chevallier A; Chedhomme FX; Abdallah F; Bachalat N; Belbachir SA; Boulaich I; Bloch V; Delahaye A; Depoisson M; Wojcicki AD; Gibaud S; Grancher AS; Guinot C; Lachuer C; Lechowski L; Leglise P; Mahiou A; Meaume S; Michel C; Michelon H; Orven Y; Perquy I; Piccoli M; Rabus M; Ribemont AC; Rwabihama JP; Trouvin JH; Ruiz F; Boudy V
    BMC Geriatr; 2019 Dec; 19(1):344. PubMed ID: 31810442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral dosage forms for children: acceptability and palatability].
    Kojima J
    Yakugaku Zasshi; 2015; 135(2):245-7. PubMed ID: 25747220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory incentives to ensure better medicines for older people: From ICH E7 to the EMA reflection paper on quality aspects.
    van Riet-Nales DA; Hussain N; Sundberg KA; Eggenschwyler D; Ferris C; Robert JL; Cerreta F
    Int J Pharm; 2016 Oct; 512(2):343-351. PubMed ID: 27150947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptability of Mini-Tablets in Young Children: Results from Three Prospective Cross-over Studies.
    Klingmann V
    AAPS PharmSciTech; 2017 Feb; 18(2):263-266. PubMed ID: 27714698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients.
    Walsh J; Cram A; Woertz K; Breitkreutz J; Winzenburg G; Turner R; Tuleu C;
    Adv Drug Deliv Rev; 2014 Jun; 73():14-33. PubMed ID: 24614069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.